| Mrs Lauren Cathleen Hopkins, DO | |
|
3500 Nw 56th St Ste 100, Oklahoma City, OK 73112-4517 | |
| (405) 951-2855 | |
| Not Available |
| Full Name | Mrs Lauren Cathleen Hopkins |
|---|---|
| Gender | Female |
| Speciality | Family Practice |
| Experience | 17 Years |
| Location | 3500 Nw 56th St Ste 100, Oklahoma City, Oklahoma |
| Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1013172683 | NPI | - | NPPES |
| 4650 | Other | OK | STATE LICENSE |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207Q00000X | Family Medicine | 4650 (Oklahoma) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Mercy Hospital Oklahoma City, Inc | Oklahoma city, OK | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Mercy Clinic Oklahoma Communities | 1153468921 | 485 |
News Archive
Incline Therapeutics, Inc., a privately-held, hospital-focused specialty pharmaceutical company, announced today that it has entered into an agreement to acquire the rights to IONSYS™ (fentanyl iontophoretic transdermal system) from ALZA Corporation and completed a $43 million Series A financing.
Swelling of lymph nodes in the armpit area is a normal response to COVID-19 vaccinations, but when they are seen on mammograms, they can be mistaken for nodes that are swollen because of cancer. In some cases, the nodes are biopsied to confirm they are not cancer.
Techulon™ Inc., an early stage life sciences company based in the Virginia Tech Corporate Research Center, has signed an exclusive license with Virginia Tech Intellectual Properties Inc. to market a new theranostic transfection reagent. This new traceable reagent complements Techulon's currently marketed Glyocofect™ transfection platform and expands the company's offering in an $800 million market that is steadily growing at 15% annually.
A retrospective analysis of 1,234 Americans indicated a substantial underdiagnosis of obesity when Body Mass Index was used compared to the Dual Energy X-ray Absorptiometry scan. This analysis will be released on Friday, April 23, 2010 at the American Association of Clinical Endocrinologists 19th Annual Meeting & Clinical Congress in Boston.
A study has shown that a daily probiotic drink changed how cells lining the nasal passages of hay fever sufferers reacted to a single out-of-season challenge. However, it did not lead to significant changes in hay fever symptoms, although this challenge test may not have accurately represented natural allergen exposure.
› Verified 1 days ago
| Entity Name | Mercy Clinic Oklahoma Communities |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1386874550 PECOS PAC ID: 1153468921 Enrollment ID: O20091027000755 |
News Archive
Incline Therapeutics, Inc., a privately-held, hospital-focused specialty pharmaceutical company, announced today that it has entered into an agreement to acquire the rights to IONSYS™ (fentanyl iontophoretic transdermal system) from ALZA Corporation and completed a $43 million Series A financing.
Swelling of lymph nodes in the armpit area is a normal response to COVID-19 vaccinations, but when they are seen on mammograms, they can be mistaken for nodes that are swollen because of cancer. In some cases, the nodes are biopsied to confirm they are not cancer.
Techulon™ Inc., an early stage life sciences company based in the Virginia Tech Corporate Research Center, has signed an exclusive license with Virginia Tech Intellectual Properties Inc. to market a new theranostic transfection reagent. This new traceable reagent complements Techulon's currently marketed Glyocofect™ transfection platform and expands the company's offering in an $800 million market that is steadily growing at 15% annually.
A retrospective analysis of 1,234 Americans indicated a substantial underdiagnosis of obesity when Body Mass Index was used compared to the Dual Energy X-ray Absorptiometry scan. This analysis will be released on Friday, April 23, 2010 at the American Association of Clinical Endocrinologists 19th Annual Meeting & Clinical Congress in Boston.
A study has shown that a daily probiotic drink changed how cells lining the nasal passages of hay fever sufferers reacted to a single out-of-season challenge. However, it did not lead to significant changes in hay fever symptoms, although this challenge test may not have accurately represented natural allergen exposure.
› Verified 1 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Mrs Lauren Cathleen Hopkins, DO 3500 Nw 56th St Ste 100, Oklahoma City, OK 73112-4517 Ph: () - | Mrs Lauren Cathleen Hopkins, DO 3500 Nw 56th St Ste 100, Oklahoma City, OK 73112-4517 Ph: (405) 951-2855 |
News Archive
Incline Therapeutics, Inc., a privately-held, hospital-focused specialty pharmaceutical company, announced today that it has entered into an agreement to acquire the rights to IONSYS™ (fentanyl iontophoretic transdermal system) from ALZA Corporation and completed a $43 million Series A financing.
Swelling of lymph nodes in the armpit area is a normal response to COVID-19 vaccinations, but when they are seen on mammograms, they can be mistaken for nodes that are swollen because of cancer. In some cases, the nodes are biopsied to confirm they are not cancer.
Techulon™ Inc., an early stage life sciences company based in the Virginia Tech Corporate Research Center, has signed an exclusive license with Virginia Tech Intellectual Properties Inc. to market a new theranostic transfection reagent. This new traceable reagent complements Techulon's currently marketed Glyocofect™ transfection platform and expands the company's offering in an $800 million market that is steadily growing at 15% annually.
A retrospective analysis of 1,234 Americans indicated a substantial underdiagnosis of obesity when Body Mass Index was used compared to the Dual Energy X-ray Absorptiometry scan. This analysis will be released on Friday, April 23, 2010 at the American Association of Clinical Endocrinologists 19th Annual Meeting & Clinical Congress in Boston.
A study has shown that a daily probiotic drink changed how cells lining the nasal passages of hay fever sufferers reacted to a single out-of-season challenge. However, it did not lead to significant changes in hay fever symptoms, although this challenge test may not have accurately represented natural allergen exposure.
› Verified 1 days ago
Alyssa Penick, Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 608 Nw 9th St Ste 1100, Oklahoma City, OK 73102 Phone: 405-231-3000 | |
Dr. Carl Patrick Griffin, M.D. Family Medicine Medicare: Medicare Enrolled Practice Location: 3555 Nw 58th St, Suite 801, Oklahoma City, OK 73112 Phone: 405-840-7003 Fax: 405-840-8221 | |
Dewey C Scheid, MD Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 900 Ne 10th St, Oklahoma City, OK 73104 Phone: 405-271-4311 Fax: 405-271-2797 | |
Dr. Johnaqa Saidi, M.D. Family Medicine Medicare: Not Enrolled in Medicare Practice Location: 9220 S Pennsylvania Ave Ste A, Oklahoma City, OK 73159 Phone: 405-691-4497 Fax: 405-692-8807 | |
Dr. Gurdeep Singh Grewal, MD Family Medicine Medicare: Not Enrolled in Medicare Practice Location: 900 Ne 10th St, Oklahoma City, OK 73104 Phone: 405-271-4311 | |
Dr. Cynthia M Brennan, M.D. Family Medicine Medicare: Not Enrolled in Medicare Practice Location: 9100 N May Ave, Oklahoma City, OK 73120 Phone: 405-840-4456 Fax: 405-840-4295 |